Finzati - Logo
ELVN logo

Enliven Therapeutics, Inc.

ELVN • Biotechnology
$59.32
▼ -0.33 (-0.55%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.93B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 28.66Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:48 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$59.32
Change-0.55%
Shares Out66.17M
Market Cap$3.93B
Enterprise Value$3.03B
52W Range14.79 - 62.32
Beta0.24
P/E-37.06
P/B4.39
P/FCF-58.55
EV/EBITDA-26.44
EV/FCF-45.21

Investment DNA

How strong this company looks for long-term investors

46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 28.66Weak profitability

Analyst view

Analyst sentiment and price target

ELVN
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
100/100
Bullish
Bullish
9
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$62.00
Mean
$73.40
Median
$78.00
High
$82.00

Company Overview

IPO: 3/12/2020
Industry: Biotechnology
P/B i: 4.39
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.00
Current Ratio: 28.66
Quick Ratio: 28.66
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Derynck Mika K
Transaction: 08/04/2026
SELL
Change
-23,364
Price
$14.85
Filing
08/06/2026
Type
SELL
Derynck Mika K
Transaction: 08/04/2026
SELL
Change
-158,795
Price
$60.21
Filing
08/06/2026
Type
SELL
Collins Helen Louise
Transaction: 07/17/2026
SELL
Change
-63
Price
$53.92
Filing
07/21/2026
Type
SELL